Identifying and comparing health-related R & D in government budget appropriations and outlays for R & D: GBAORD / Alison Young -- Compiling performer-reported health GERD / Alison Young -- Improving national surveys and their international comparability: clinical trials and R & D in hospitals / Alison Young -- Other views and classifications of health-related R & D / Alison Young -- Health research and experimental development in Australia / Derek Byars -- Measuring health R & D in Austria / Karl Messmann -- Estimates of gross expenditures on R & D in the health field in Canada / Paul McPhie -- R & D in the Danish health sector / Henrik Troelsen and Karen Siune -- Estimating health-related R & D expenditure in France / Monique Bonneau -- Measuring resources devoted to health-related R & D in Israel / Soli Peleg and Nava Brenner -- Measuring health-related R & D in Norway / Susanne Lehmann Sundnes -- Research in the Spanish health services / Carlos Angulo -- Measuring health-related R & D in the United Kingdom / Fiona Russell and Derek Gardiner -- Estimates of health R & D expenditures in the United States: an exploratory data compilation / John E. Jankowski
Summary
Science and technology improves human health but the pressure for faster and larger improvements is building with the continued ageing of the population of many OECD countries and the associated increased demands for health care. A fundamental starting point for better understanding of the impact of innovation on health is the measurement of R & D. This publication addresses this issue by looking in detail at measurement practices across ten OECD member countries as well as the main international sources
